GSKCONS

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange information as per Regulation 13(3) and 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992. The details of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gskcons_reg_23122009.zip target=NEW> For more details click here.</a>

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that "We had informed that due to unrest in the state of Andhra Pradesh and bandh called in the state by political parties, the management of GlaxoSmithKline Consumer Healthcare Limited temporarily suspended operations at one of its factories located at Industrial Estate Dowlaiswaram, Andhra Pradesh -533124. This is to inform you that the operations at the said factory have now resumed."

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "Due to unrest in the State of Andhra Pradesh and bandh called in the state by political parties, the management of Glaxosmithkline Consumer Healthcare Limited has decided to suspend operations temporarily at one of its factory located at Industrial Estate Dowlaiswaram, Andhra Pradesh - 533124 with effect from morning of today, December 11, 2009 in the interest of safety and security of its employees and to protect the assets of the factory".

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2009 as follows: Net Sales of Rs. 49506 lacs for quarter ending on 30-SEP-2009 against Rs. 42248 lacs for the quarter ending on 30-SEP-2008. Net Profit / (Loss) of Rs. 6002 lacs for the quarter ending on 30-SEP-2009 against Rs. 5303 lacs for the quarter ending on 30-SEP-2008.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of Abstract of the terms and conditions of the appointment and remuneration of Mr. Ramakrishnan Subramanian as a Wholetime Director has been circulated to all members of the Company on August 12, 2009, as per the requirements of Section 302 of Companies, Act, 1956. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gSK_abstract_20082009.zip target=NEW> For

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange that the auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009 and the year to date results for the period January 1, 2009 to June 30, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKCONS_LR_30072009.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors at a meeting held on July 29, 2009. The following items which were also approved at the board meeting: 1) Proposed appointment of Mr. Zubair Ahmed as Non-Executive Director on the Board of M/s. Raheja Builders Private Ltd. 2) Appointment of Mr. Ramakrishnan Subramanian, the CFO of the Company, as Wholetime Director w.e.f. August 1, 2009 subsequent to his nomination by Horlicks Ltd., under Article 97-A of the Articles of Association of the Company. 3) Investment of up to Rs. 200 Crores for enhancem

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-JUN-2009 as follows: Net Sales of Rs. 100908 lacs for half year ending on 30-JUN-2009 against Rs. 78693 lacs for the half year ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 13908 lacs for the half year ending on 30-JUN-2009 against Rs. 10272 lacs for the half year ending on 30-JUN-2008.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2009 as follows: Net Sales of Rs. 46872 lacs for quarter ending on 30-JUN-2009 against Rs. 37637 lacs for the quarter ending on 30-JUN-2008. Net Profit / (Loss) of Rs. 5519 lacs for the quarter ending on 30-JUN-2009 against Rs. 4616 lacs for the quarter ending on 30-JUN-2008.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the minutes of the proceedings of the Annual General Meeting of the members of the Company held on April 24, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSk_MINAGM_06052009.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the auditor's have conducted the limited review of the Unaudited financial results for the quarter ended March 31, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKCONS_LR_24042009.zip target=NEW> For more details click here.</a>

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2009 as follows: Net Sales of Rs. 53937 lacs for quarter ending on 31-MAR-2009 against Rs. 41060 lacs for the quarter ending on 31-MAR-2008. Net Profit / (Loss) of Rs. 8389 lacs for the quarter ending on 31-MAR-2009 against Rs. 5660 lacs for the quarter ending on 31-MAR-2008.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that at the Annual General Meeting held on April 24, 2009 all the items of business contained in the Notice of the Annual General Meeting of the Company were approved by the Members, Who: (1) Approved the audited Balance Sheet and Profit and Loss Account for the year ended December 31, 2008 together with the Directors' Report and Auditors' Report thereon. (2) Approved final dividend of Rs.5.00 per equity share of Rs.10 each for the year ended December 31, 2008 and confirmed the Interim Dividend amounting to Rs.10.00 per equi

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that Mr Ramakrishnan Subramanian, Director- Finance & IT and CFO of the Company, a Nominee Director of the Company's Promoters, Horlicks Ltd. under Article 97 A of the Articles of Association of the Company, has resigned as Director of the Company w.e.f the close of business hours of March 30, 2009, upon withdrawal of his nomination. The Company has also informed that Mr Ramakrishnan Subramanian will however continue as Chief Financial Officer of the Company.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members and Share Transfer Books will remain closed from April 16, 2009 to April 24, 2009, both days inclusive, for the purpose of Dividend and Annual General Meeting. Further, the Annual General Meeting of the members of the Company will be held on April 24, 2009.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 27, 2009 has recommended a Final Dividend of Rs. 5/- per equity share of Rs. 10/- each for the year ended December 31, 2008.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-DEC-2008 as follows: Net Sales of Rs. 154278 lacs for year ending on 31-DEC-2008 against Rs. 127780 lacs for the year ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 18833 lacs for the year ending on 31-DEC-2008 against Rs. 16260 lacs for the year ending on 31-DEC-2007.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2008 as follows: Net Sales of Rs. 33337 lacs for quarter ending on 31-DEC-2008 against Rs. 28410 lacs for the quarter ending on 31-DEC-2007. Net Profit / (Loss) of Rs. 3258 lacs for the quarter ending on 31-DEC-2008 against Rs. 2750 lacs for the quarter ending on 31-DEC-2007.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from employees of the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Glaxo_Dis_21012009.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from employees of the Company under SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKCons_Dis_21022009.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that for the last quarter of the financial year of the Company ending on December 31, 2008. The Company shall be submitting Audited financial results for the entire financial year. Accordingly, company shall not be submitting the unaudited financial results for the last quarter October 1, 2008 to December 31, 2008.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on October 24, 2008 has declared an interim dividend of Rs.10/- per equity share for the year ending December 31, 2008 and has fixed October 31, 2008 as the record date for this purpose. Dividend warrants in respect to the proposed dividend will be made payable on or before November 18, 2008.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 42248 lacs for quarter ending on 30-SEP-2008 against Rs. 35160 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 5303 lacs for the quarter ending on 30-SEP-2008 against Rs. 5050 lacs for the quarter ending on 30-SEP-2007.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-JUN-2008 as follows: Net Sales of Rs. 78693 lacs for half year ending on 30-JUN-2008 against Rs. 64210 lacs for the half year ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 10272 lacs for the half year ending on 30-JUN-2008 against Rs. 8460 lacs for the half year ending on 30-JUN-2007.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 37637 lacs for quarter ending on 30-JUN-2008 against Rs. 31560 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 4616 lacs for the quarter ending on 30-JUN-2008 against Rs. 4230 lacs for the quarter ending on 30-JUN-2007.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the minutes of the proceedings of the Annual General Meeting of the members of the Company held on April 25, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKCON_Min_27052008.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange outcome of the Annual General Meeting of the Company held on April 25, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Glaxosmith_Pro_AGM_02052008.zip target=NEW> For more details click here.</a>

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 41060 lacs for quarter ending on 31-MAR-2008 against Rs. 32650 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 5660 lacs for the quarter ending on 31-MAR-2008 against Rs. 4230 lacs for the quarter ending on 31-MAR-2007.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members of the Company shall remain closed from April 17, 2008 to April 24, 2008 (both days inclusive) for taking on record the shareholders for the purpose of the Annual General Meeting of the equity shareholders scheduled to be held on April 25, 2008.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of an Abstract of the terms and conditions of the appointment and remuneration of Mr. Ramakrishnan Subramanian, Wholetime Director and variation in the term of remuneration of Mr. Praveen K Gupta, Wholetime Director. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/Glaxo_Abs_14022008.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "Mr.Ramakrishnan Subramanian has been nominated as Nominee Director of Horlicks Limited, U.K., w.e.f. December 1, 2007 in place of Mr. Gautam K Chakraborty as the Director - Finance & IT. Please note that the Board of Directors, in their meeting held on January 29, 2008, have taken note of the nomination of Mr. Ramakrishnan Subramanina as a Director".

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the year ended on 31-DEC-2007 as follows: Net Sales of Rs. 127780 lacs for year ending on 31-DEC-2007 against Rs. 111190 lacs for the year ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 16260 lacs for the year ending on 31-DEC-2007 against Rs. 12690 lacs for the year ending on 31-DEC-2006.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 28410 lacs for quarter ending on 31-DEC-2007 against Rs. 26470 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 2750 lacs for the quarter ending on 31-DEC-2007 against Rs. 2520 lacs for the quarter ending on 31-DEC-2006.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from employees of the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_reg_28012008.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "Mr.Ramakrishnan Subramanian has been nominated as Nominee Director of Horlicks Limited, U.K., w.e.f. December 1, 2007 in place of Mr. Gautam K Chakraborty as the Director - Finance & IT. This will be placed before the next Board meeting of the Company".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Board has declared an interim dividend of Rs.12.00 per equity share for the year ending December 31, 2007.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that: "Mr. Gautam K Chakraborty, Director - Finance & IT and CFO of the Company, a nominee Director of the Company's Promoters, Horlicks Ltd., under Article 97 A of the Articles of Association of the Company, is resigning as Director of the Company w.e.f. November 30, 2007 upon withdrawal of his nomination".

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that "The Company has appointed Karvy Computershare Private Limited (KCPL) as the Company's Register & Transfer Agent (RTA) w.e.f. 01.09.2007. The contact details of KCPL, the new RTA are given below: M/s Karvy Computershare Private Limited. Unit: Glaxosmithkline Consumer Healthcare Limited. Plot No. 17 to 24, Vittalrao Nagar, Madhapur, Hyderabad - 500081. Phone Numbers : 040-23420818 and 828 Fax. No. 040-23420814 Toll free Number (18003454001)".

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the half year ended on 30-JUN-2007 as follows: Net Sales of Rs. 64210 lacs for half year ending on 30-JUN-2007 against Rs. 54572 lacs for the half year ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 8460 lacs for the half year ending on 30-JUN-2007 against Rs. 6538 lacs for the half year ending on 30-JUN-2006.

GlaxoSmithKline Consumer Healthcare Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-JUN-2007 as follows: Net Sales of Rs. 31560 lacs for quarter ending on 30-JUN-2007 against Rs. 26881 lacs for the quarter ending on 30-JUN-2006. Net Profit / (Loss) of Rs. 4230 lacs for the quarter ending on 30-JUN-2007 against Rs. 3092 lacs for the quarter ending on 30-JUN-2006.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of the minutes of the proceedings of the Forty Eighth Annual General Meeting of the members of the Company held on April 27, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKGlaxoHealthcare.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the following persons have been elected as Directors of the Company at the Annual General Meeting held on April 27, 2007. These Directors have been appointed under a system of proportional representation and shall hold office for a period of three years with effect from April 27, 2007 up to the Annual General meeting of 2010. The Directors appointed are: (1) Mr. Praveen K. Gupta. (2) Mr. P Dwarakanath. (3) Mr. Ashok Dayal. (4) Mr. P Murari. (5) Mr. Kunal Kashyap. (6) Mr. Subodh Bhargava.

Glaxosmithkline Consumer Healthcare Limited has informed the Exchange that the Register of Members of the Company shall remain closed from April 18, 2007 to April 26, 2007 (both days inclusive) for taking on record the shareholders for the purpose of the Annual General Meeting of the equity shareholders scheduled to be held on April 27, 2007.

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated February 08, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_reg1_130207.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated February 07, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSKCONS_090207.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure form as received from the following: (i) Name of Declaring Person - Nitin Mathur (ii) Designation of Declaring Person - Manager - Finance. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/GSK_ITREG_07022007.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 12, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxocons_dec-170107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 15, 2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_dec_170107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 08,2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/glaxo_annualdec_120107.zip target=NEW> For more details click here.</a>

Glaxosmithkline Consumer Healthcare Limited has submitted to the Exchange a copy of annual declaration / disclosure forms as per letter dated January 10 ,2007. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements).<a href=/content/corporate/gsk_Annual_120107.zip target=NEW> For more details click here.</a>